DK1558755T3 - Frengangsmåde til bestemmelse af specifikke grupper, som indgår i hepariner - Google Patents

Frengangsmåde til bestemmelse af specifikke grupper, som indgår i hepariner

Info

Publication number
DK1558755T3
DK1558755T3 DK03772376.4T DK03772376T DK1558755T3 DK 1558755 T3 DK1558755 T3 DK 1558755T3 DK 03772376 T DK03772376 T DK 03772376T DK 1558755 T3 DK1558755 T3 DK 1558755T3
Authority
DK
Denmark
Prior art keywords
heparins
groups included
specific groups
determining specific
determining
Prior art date
Application number
DK03772376.4T
Other languages
English (en)
Inventor
Pierre Mourier
Christian Viskov
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Priority claimed from PCT/FR2003/002782 external-priority patent/WO2004027087A2/fr
Application granted granted Critical
Publication of DK1558755T3 publication Critical patent/DK1558755T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK03772376.4T 2002-09-23 2003-09-22 Frengangsmåde til bestemmelse af specifikke grupper, som indgår i hepariner DK1558755T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0211724A FR2844808B1 (fr) 2002-09-23 2002-09-23 Methode de determination de groupements specifiques constituant les heparines ou les heparines de bas poids moleculaire
US42248202P 2002-10-31 2002-10-31
PCT/FR2003/002782 WO2004027087A2 (fr) 2002-09-23 2003-09-22 Methode de determination de groupements specifiques constituant les heparines

Publications (1)

Publication Number Publication Date
DK1558755T3 true DK1558755T3 (da) 2013-02-11

Family

ID=31970889

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03772376.4T DK1558755T3 (da) 2002-09-23 2003-09-22 Frengangsmåde til bestemmelse af specifikke grupper, som indgår i hepariner

Country Status (9)

Country Link
US (1) US20050119477A1 (da)
CN (2) CN100350054C (da)
AR (1) AR041320A1 (da)
DK (1) DK1558755T3 (da)
ES (1) ES2398102T3 (da)
FR (1) FR2844808B1 (da)
PT (1) PT1558755E (da)
SI (1) SI1558755T1 (da)
ZA (1) ZA200501741B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2402753A1 (en) 2002-03-11 2012-01-04 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
FR2880951B1 (fr) * 2005-01-19 2015-09-18 Aventis Pharma Sa Methode d'analyse d'oligosaccharides a partir de plasma sanguin
US8101733B1 (en) 2006-06-27 2012-01-24 Momenta Pharmaceuticals, Inc. Methods of evaluating mixtures of polysaccharides
US7968082B1 (en) 2007-01-26 2011-06-28 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by NMR
US7790466B1 (en) 2007-01-26 2010-09-07 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2817779T3 (es) * 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluación de preparaciones de heparina
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102323355B (zh) * 2011-08-22 2013-10-16 深圳市天道医药有限公司 一种酶解-hplc法检测依诺肝素的方法
CN102759596B (zh) * 2012-07-09 2014-08-20 山东大学 一种低分子肝素的离子对反相色谱质谱联用检测方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002400A1 (en) * 1986-10-02 1988-04-07 Massachusetts Institute Of Technology Neutralizing anticoagulant activities of low molecular weight heparin
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US4981955A (en) * 1988-06-28 1991-01-01 Lopez Lorenzo L Depolymerization method of heparin
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
US5389539A (en) * 1992-11-30 1995-02-14 Massachusetts Institute Of Technology Purification of heparinase I, II, and III from Flavobacterium heparinum
US6190875B1 (en) * 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US6617316B1 (en) * 1999-10-22 2003-09-09 Aventis Pharma Oligosaccharides, their preparation and pharmaceutical compositions containing them
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
US6608042B2 (en) * 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof

Also Published As

Publication number Publication date
FR2844808B1 (fr) 2005-02-25
FR2844808A1 (fr) 2004-03-26
PT1558755E (pt) 2013-01-29
CN1703519A (zh) 2005-11-30
SI1558755T1 (sl) 2013-02-28
CN1990495A (zh) 2007-07-04
CN100350054C (zh) 2007-11-21
ZA200501741B (en) 2006-06-28
ES2398102T3 (es) 2013-03-13
AR041320A1 (es) 2005-05-11
US20050119477A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
BRPI0313238A2 (pt) método
IS3028B (is) Þurrkunaraðferð
DK1997512T3 (da) Fremgangsmåder til behandling af TWEAK-relaterede tilstande
DK1492785T3 (da) 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer
DE60313872D1 (de) Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
DK1824855T3 (da) Hidtil ukendte pyrrolo (3,2-d)pyrimidin-4-onderivater og anvendelser af disse til behandling
FI20031156A0 (fi) Liotusmenetelmä
DK1537291T3 (da) Borefremgangsmåde
DK1529072T3 (da) Fremgangsmåder til ekstraktion af polymere
FR2843963B1 (fr) Nouvelles molecules derivees de la noraporphine
DE602004012154D1 (de) Pyridoä2,3-düpyrimidin-2,4-diamine als pde-2-inhibitoren
FI20020479A (fi) Pintakäsittelyprosessi
DE50303161D1 (de) Zentrierspanner
DK1668125T3 (da) Modificerede enzymer, fremgangsmåde til fremstilling af modificerede enzymer og anvendelser deraf
DE60200707D1 (de) Zitterhistogrammnäherungsverfahren
DK1558755T3 (da) Frengangsmåde til bestemmelse af specifikke grupper, som indgår i hepariner
DE602004027813D1 (de) Blockcopolymerzusammensetzung
DE602004017418D1 (de) Fluorpolymerdichtungsmittel
DE602004021074D1 (de) Platinbeschichtungsverfahren
DK1578442T3 (da) Fremgangsmåde til isolering af endotoxiner
FI20022034A (fi) Päällystysmenetelmä
FI20031389A0 (fi) Menetelmä viilun sorvaamiseksi
FI20030627A0 (fi) Menetelmä ja järjestely kaasunpoistossa, sekä niiden käyttö
FI20020748A0 (fi) Kosteiden tilojen kiinnitysmenetelmä/tekniikka